A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
Phase 3
Completed
- Conditions
- Cognition DisorderNervous System DiseasesMental DisordersBrain Diseases
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 724
- Registration Number
- NCT00240695
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
Phase 3
Completed
- Conditions
- SchizophreniaPsychotic Disorders
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 1
- Registration Number
- NCT00236548
A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
Phase 3
Completed
- Conditions
- EpilepsySeizures
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 80
- Registration Number
- NCT00236704
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
Phase 3
Completed
- Conditions
- ContraceptionFemale Contraception
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-11-17
- Target Recruit Count
- 1751
- Registration Number
- NCT00236769
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
Phase 3
Completed
- Conditions
- EpilepsyEpilepsies, PartialEpilepsy, GeneralizedSeizures
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 49
- Registration Number
- NCT00236886
A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
Phase 3
Completed
- Conditions
- Obesity
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 1293
- Registration Number
- NCT00236639
A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension
Phase 3
Completed
- Conditions
- ObesityHypertension
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 531
- Registration Number
- NCT00236665
A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program
Phase 3
Completed
- Conditions
- Obesity
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-04-28
- Target Recruit Count
- 561
- Registration Number
- NCT00236600
A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
Phase 3
Completed
- Conditions
- MigraineCommon MigraineClassic MigraineHeadache
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-11-19
- Target Recruit Count
- 786
- Registration Number
- NCT00236561
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
Phase 3
Completed
- Conditions
- MigraineCommon MigraineClassic MigraineHeadache
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-11-17
- Target Recruit Count
- 763
- Registration Number
- NCT00236509
© Copyright 2025. All Rights Reserved by MedPath